This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Corbus Pharmaceuticals Holdings Inc. slid 3.8% to $5.31 on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 1.0% to 42,001.76 and the NASDAQ Composite Index falling 0.1% to 17,299.29.

This was the stock's fourth consecutive day of losses.

Corbus Pharmaceuticals Holdings Inc. closed 91.4% short of its 52-week high of $61.90, which the company achieved on July 31st.

The stock demonstrated a mixed performance when compared to some of its competitors, as Vanda Pharmaceuticals Inc. fell 2.1% to $4.59, Fortress Biotech Inc. fell 3.1% to $1.56, and Viking Therapeutics Inc. fell 5.85% to $24.15.

Trading volume totaled 226,168, compared to the 50-day average of 253,153.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

March 31, 2025 16:34 ET (20:34 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.